High-fat diet–induced glucose intolerance is prevented in ghrelin knockout (Ghr-KO) mice. High-fat diet–induced glucose intolerance is prevented in ghrelin.

Slides:



Advertisements
Similar presentations
Chapter 8. Fig 23.1  “Competition eating” ◦ Eating strategies  Before, during and after competition ◦ “preparation”  Weeks, months prior.
Advertisements

The FATZO mouse as a Translational Model for the Development of Drugs for Obesity, Metabolic Syndrome and Diabetes. PreClinOmics, Inc. 1.
DIET CONTROL  All diabetic patients should be on diet control.  Diet control is a must either the patient is taking insulin or oral therapy.  Over.
Could Cooked Meat Hold A Risk Factor For Dementia And Diabetes?
Figure Legend: From: High-Fat Diet–Induced Retinal Dysfunction
Glucose homeostasis: roles of insulin, glucagon, amylin, and GLP-1.
(A) Fasting serum glucose (mg/dL), (B) fasting serum insulin (μU/mL), (C) plasma glycated albumin (GA; %) and (D) plasma fructosamine (μmol/L) measured.
Flowchart of literature search for the effect of fructose on glycemic end points (fasting glucose, fasting insulin, and glycated blood proteins [HbA1c.
Impaired glucose tolerance in adult S1/3 KO mice on a normal chow
Dandan Wang et al. BTS 2018;3: Diabetes Exacerbates Myocardial Infarction and Ischemia/Reperfusion Injury (A) Comparison of fasting blood glucose.
The insulin tolerance test at week 18.
Fig. 1. Body weight gain in Cbx7-KO mice
Cellularity of epididymal adipose tissue.
Overexpression of BTG2 resulted in an increase in hepatic gluconeogenesis. Overexpression of BTG2 resulted in an increase in hepatic gluconeogenesis. A:
Deletion of neuronal insulin receptor signaling reduces TG secretion, while the targeted knockout of insulin receptors restricted to the periphery increases.
Effects of insulin administration in streptozotocin-treated mice.
Changes (mean +SEM) in glucose, insulin, glucagon-like peptide (GLP)-1 and ghrelin from the baseline values after administration of placebo (broken lines.
Exogenous CRP administration causes fasting hyperglycemia and hyperinsulinemia without altering body composition. Exogenous CRP administration causes fasting.
1018-NT-β-cell clusters protect mice from STZ-induced diabetes.
WASH cKO mice display a normal pancreatic development.
TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin resistance. TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin.
Transplantation of the ω3-modified microbiome as a relevant way to preserve a lean phenotype in mice fed the HFHS diet. Transplantation of the ω3-modified.
GSIS. GSIS. In vivo: serum insulin levels at fasting state and 30 min after glucose injection (A) and the fold change in serum insulin after glucose loading.
Activation of β-adrenoceptors improves glucose tolerance in diabetic animals and increases glucose uptake in vivo, ex vivo, and in vitro. Activation of.
A: The change of plasma glucose in opioid μ-receptor knockout diabetic mice and wild-type controls receiving an oral intake of metformin (100 mg/kg). A:
FGF21 signaling in hypothalamus is blocked by FGFR1 neutralizing antibody. FGF21 signaling in hypothalamus is blocked by FGFR1 neutralizing antibody. Twelve-week-old.
Nrf2−/− mice suffered greater renal damage by STZ compared with Nrf2+/+ mice. Nrf2−/− mice suffered greater renal damage by STZ compared with Nrf2+/+ mice.
Modulation of insulin sensitivity by IL-6 in mice: A lack of PTP1B prevents chronic effects of IL-6. Modulation of insulin sensitivity by IL-6 in mice:
Plasma growth hormone concentrations during a 65-min infusion of acyl ghrelin at 0.3, 0.9, or 1.5 nmol/kg/h, or saline. Plasma growth hormone concentrations.
TXNIP and caspase-1 protein levels are increased in the adipose tissue of ob/ob mice. TXNIP and caspase-1 protein levels are increased in the adipose tissue.
Loss of protection by linagliptin against obesity-related inflammation and insulin resistance in MIP-1α−/− mice. Loss of protection by linagliptin against.
Measurement of insulin release from islets evoked by glucose, diazoxide, and high K+. Measurement of insulin release from islets evoked by glucose, diazoxide,
Transgenic restoration of long-chain n-3 PUFA protects against obesity-linked insulin resistance and glucose intolerance. Transgenic restoration of long-chain.
Effects of in vivo AICAR treatment on blood glucose and lactate concentrations. Effects of in vivo AICAR treatment on blood glucose and lactate concentrations.
ΑGLP-1R−/− mice show glucose intolerance and disturbed glucagon secretion in response to i.p. glucose administration. αGLP-1R−/− mice show glucose intolerance.
Reduced β-cell mass in MCH-KO mice on normal chow and high-fat diets.
BAFF-deficient (BAFFnull) and anti-BAFF antibody (Ab)–treated obese mice exhibit superior glucose metabolic control compared with WT and Bnull mice. BAFF-deficient.
Substrate oxidation and contractile performance of Akita hearts
The effect of VSG on body weight and body fat in GLP-1r KO mice.
GLP-1 and gastrin combination therapy restores normoglycemia in NOD mice. GLP-1 and gastrin combination therapy restores normoglycemia in NOD mice. Beginning.
A: Chemical structure of pterosin A
Chop deletion preserves β-cell function in P58IPK−/− mice.
Reduced OXPHOS expression and increased UCP expression.
Adoptive transfer of purified activated G9Cα−/−
Metabolic parameters of Id1−/− and wild-type mice fed a standard chow diet (hatched bars and striped bars, respectively) or a high-fat diet (black bars.
USP2–45 regulates hepatic gluconeogenesis.
Effect of Id1 deletion on insulin action in wild-type and Id1−/− mice fed a chow diet (white triangle/striped bar and black triangle/hatched bar, respectively)
Effect of anandamide on blood glucose clearance and insulin sensitivity. Effect of anandamide on blood glucose clearance and insulin sensitivity. A: Intraperitoneal.
The lack of effect of denatonium to stimulate insulin release in the absence of extracellular Ca2+ or in the presence of 10 μmol/l nitrendipine. The lack.
HFD feeding induced insulin resistance in TRIB3 MOE mice.
Absence of OcaB protects against age-induced insulin resistance.
Hepatic fuel metabolism in male 5αR1-KO and WT mice
Mice fed GP-SPI diet show improved fasting glucose and oral glucose tolerance. Mice fed GP-SPI diet show improved fasting glucose and oral glucose tolerance.
Hepatic PPARγ deficiency impairs the SCFA-induced reduction in hepatic steatosis. Hepatic PPARγ deficiency impairs the SCFA-induced reduction in hepatic.
Insulin resistance and hepatic steatosis in ASKO mice.
Treatment of high-fat diet–fed mice with TTR-ASOs decreases circulating TTR and RBP4 levels, and improves insulin sensitivity. Treatment of high-fat diet–fed.
MϕRIP140KD mice exhibit improved metabolic phenotypes.
Effects of Rosi treatment on ASKO mice.
Effects of chow-diet feeding on control and TRIB3 MOE mice.
Effects of berberine on in vivo metabolism in two animal models of insulin resistance. Effects of berberine on in vivo metabolism in two animal models.
Metabolic effects of VSG in GLP-1r KO mice.
GTTs and ITTs. A: GTTs of WT (◇), LepTg (♦), Akita (open circles), and LepTg:Akita (closed circles) mice at 8 and 16 weeks of age. GTTs and ITTs. A: GTTs.
Loss of Phb2 in β-cells induces development of diabetes over a 3-week period in β-Phb2−/− mice. Loss of Phb2 in β-cells induces development of diabetes.
β-Cell–specific deletion of Phb2 renders mice diabetic.
Mice lacking Y1 receptor in the hematopoietic compartment remain healthy under normal chow feeding conditions. Mice lacking Y1 receptor in the hematopoietic.
Effects of rhein on FBG (A) and glucose intolerance (B) in db/db mice.
Deficiency of adipocyte IKKβ does not affect diet-induced weigh gain but results in an exaggerated diabetic phenotype when challenged with an HFD. A: IKKβ.
Glycemic control and body weight over 52 weeks.
Volume 27, Issue 10, Pages e3 (June 2019)
Fig. 3. Effects of SFN in mice with diet-induced diabetes.
Presentation transcript:

High-fat diet–induced glucose intolerance is prevented in ghrelin knockout (Ghr-KO) mice. High-fat diet–induced glucose intolerance is prevented in ghrelin knockout (Ghr-KO) mice. Body weight (A), fed blood glucose (B), and insulin (C) levels in 12-week-old wild-type and ghrelin knockout mice fed a high-fat diet or control diet. The mice were given a high-fat diet or control diet from 8 to 12 weeks old. On a caloric base, high-fat diet consisted of 23% protein, 44.6% carbohydrates, and 32.4% fat (total 17.9 kJ/g), whereas control diet consisted of 29.2% protein, 58.8% carbohydrates, and 12% fat (total 14.5 kJ/g, n = 9 per group). In wild-type mice, the high-fat diet group exhibited glucose intolerance (D) and slight enhancement of insulin release (E) during the GTT (glucose 2 g/kg i.p.). In ghrelin knockout mice, in contrast, glycemic responses to GTTs in the high-fat diet group were not different from those of control diet group (F), and insulin response at 15 min was markedly enhanced in the high-fat diet group (G). *P < 0.05; **P < 0.01 vs. control diet mice; #P < 0.05 vs. wild-type high-fat diet mice. Katsuya Dezaki et al. Diabetes 2006;55:3486-3493 ©2006 by American Diabetes Association